Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Can Ficicioglu

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Journal of Clinical Medicine|April 14, 2026
Improvement of Bone Mineral Density in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: Results from Clinical StudiesAri Zimran, Jaco Botha, Richard Eastell, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 4, 2017
Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendationsJeffrey M Chinsky, Rani Singh, Can Ficicioglu, et al.
International Journal of Neonatal Screening|November 18, 2020
Newborn Screening for Pompe Disease: Pennsylvania ExperienceCan Ficicioglu, Rebecca C Ahrens-Nicklas, Joshua Barch, et al.
Molecular Genetics and Metabolism|January 23, 2009
A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiencyGeorgianne L Arnold, Johan Van Hove, Debra Freedenberg, et al.
Molecular Genetics and Metabolism|June 6, 2008
Complex management of a patient with a contiguous Xp11.4 gene deletion involving ornithine transcarbamylase: a role for detailed molecular analysis in complex presentations of classical diseasesMatthew A Deardorff, Himabindu Gaddipati, Paige Kaplan, et al.
Molecular Genetics and Metabolism|April 3, 2022
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?Neal J Weinreb, Ozlem Goker-Alpan, Priya S Kishnani, et al.
International Journal of Neonatal Screening|April 25, 2022
Newborn Screening for X-Linked Adrenoleukodystrophy: Review of Data and Outcomes in PennsylvaniaJessica R C Priestley, Laura A Adang, Sarah Drewes Williams, et al.
Journal of Inherited Metabolic Disease|March 4, 2024
Efficacy and safety of sapropterin before and during pregnancy: Final analysis of the Kuvan® Adult Maternal Paediatric European Registry (KAMPER) maternal and Phenylketonuria Developmental Outcomes and Safety (PKUDOS) PKU-MOMs sub-registriesFrançois Feillet, Can Ficicioglu, Florian B Lagler, et al.
Molecular Genetics and Metabolism|September 16, 2018
Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2 months to 2 years of age with urea cycle disordersSusan A Berry, Jerry Vockley, Alexander A Vinks, et al.
Metabolic Brain Disease|February 14, 2018
Treatment outcome of creatine transporter deficiency: international retrospective cohort studyTheodora U J Bruun, Sarah Sidky, Anabela O Bandeira, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Journal of Clinical Medicine|April 14, 2026
Improvement of Bone Mineral Density in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: Results from Clinical StudiesAri Zimran, Jaco Botha, Richard Eastell, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 4, 2017
Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendationsJeffrey M Chinsky, Rani Singh, Can Ficicioglu, et al.
International Journal of Neonatal Screening|November 18, 2020
Newborn Screening for Pompe Disease: Pennsylvania ExperienceCan Ficicioglu, Rebecca C Ahrens-Nicklas, Joshua Barch, et al.
Molecular Genetics and Metabolism|January 23, 2009
A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiencyGeorgianne L Arnold, Johan Van Hove, Debra Freedenberg, et al.
Molecular Genetics and Metabolism|June 6, 2008
Complex management of a patient with a contiguous Xp11.4 gene deletion involving ornithine transcarbamylase: a role for detailed molecular analysis in complex presentations of classical diseasesMatthew A Deardorff, Himabindu Gaddipati, Paige Kaplan, et al.
Molecular Genetics and Metabolism|April 3, 2022
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?Neal J Weinreb, Ozlem Goker-Alpan, Priya S Kishnani, et al.
International Journal of Neonatal Screening|April 25, 2022
Newborn Screening for X-Linked Adrenoleukodystrophy: Review of Data and Outcomes in PennsylvaniaJessica R C Priestley, Laura A Adang, Sarah Drewes Williams, et al.
Journal of Inherited Metabolic Disease|March 4, 2024
Efficacy and safety of sapropterin before and during pregnancy: Final analysis of the Kuvan® Adult Maternal Paediatric European Registry (KAMPER) maternal and Phenylketonuria Developmental Outcomes and Safety (PKUDOS) PKU-MOMs sub-registriesFrançois Feillet, Can Ficicioglu, Florian B Lagler, et al.
Molecular Genetics and Metabolism|September 16, 2018
Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2 months to 2 years of age with urea cycle disordersSusan A Berry, Jerry Vockley, Alexander A Vinks, et al.
Metabolic Brain Disease|February 14, 2018
Treatment outcome of creatine transporter deficiency: international retrospective cohort studyTheodora U J Bruun, Sarah Sidky, Anabela O Bandeira, et al.
Pageof 11